Journey Medical Corp (DERM) stock
DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3033% below fair value
$3.90+0.20 (+5.41%)
Close on Nov 17, 2026Market cap $110.08MP/E –Yield –
Journey Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Journey Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.49M. For fiscal 2025 it was -$12.44M. The highest annual figure on record is $5.24M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$12.44M | – |
| FY2024 | Dec 31, 2024 | -$9.13M | -274.2% |
| FY2023 | Dec 31, 2023 | $5.24M | – |
| FY2022 | Dec 31, 2022 | -$13.53M | – |
| FY2021 | Dec 31, 2021 | -$2.18M | -142.5% |
| FY2020 | Dec 31, 2020 | $5.13M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.73M | – |
| Q1 FY2026 | Mar 31, 2026 | $2.91M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.28M | -382.4% |
| Q3 FY2025 | Sep 30, 2025 | -$2.38M | – |
| Q2 FY2025 | Jun 30, 2025 | -$942.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.83M | – |
| Q4 FY2024 | Dec 31, 2024 | $2.23M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.16M | -106.2% |
| Q2 FY2024 | Jun 30, 2024 | -$5.18M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.02M | – |
| Q4 FY2023 | Dec 31, 2023 | -$16.52M | – |
| Q3 FY2023 | Sep 30, 2023 | $18.75M | +2020.7% |
| Q4 FY2022 | Dec 31, 2022 | -$3.84M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.28M | -202.5% |
| Q2 FY2022 | Jun 30, 2022 | -$3.30M | – |
| Q1 FY2022 | Mar 31, 2022 | $884.00K | -35.0% |
| Q4 FY2021 | Dec 31, 2021 | -$3.21M | -163.4% |
| Q3 FY2021 | Sep 30, 2021 | $7.10M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.44M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.36M | – |
| Q4 FY2020 | Dec 31, 2020 | $5.05M | – |
See a number that looks wrong?